Sahbaz A, Selcuk B, Domac F, Demir S, Koseoglu M, Uludasdemir E
Biochem Genet. 2025; .
PMID: 40072812
DOI: 10.1007/s10528-025-11077-4.
Salih S, Hashim A, Hasrat N, Farid H
Cureus. 2025; 17(2):e78530.
PMID: 40062043
PMC: 11885895.
DOI: 10.7759/cureus.78530.
Zhu X, Wang P, Chao S, Tang W, Zhao L, Yu L
J Transl Med. 2025; 23(1):260.
PMID: 40038710
PMC: 11877847.
DOI: 10.1186/s12967-025-06296-7.
Ibrahim D, Schwarz K, Suiwal S, Maragkou S, Schmitz F
Cells. 2025; 14(3).
PMID: 39936997
PMC: 11816939.
DOI: 10.3390/cells14030206.
Zachariou A, Baltogiannis D, Zikopoulos A, Sapouna V, Giannakis I, Kaltsas A
Cureus. 2025; 17(1):e77306.
PMID: 39935935
PMC: 11811673.
DOI: 10.7759/cureus.77306.
Physicians' Perspectives on Barriers to Multiple Sclerosis Care in the United Arab Emirates: A Survey Study.
Mir R, Brylev L, Zahoorudin S, Rivero Jimenez R, Servano R, Castillo-Aleman Y
Cureus. 2025; 17(1):e77281.
PMID: 39931587
PMC: 11809462.
DOI: 10.7759/cureus.77281.
Subject-Based Transfer Learning in Longitudinal Multiple Sclerosis Lesion Segmentation.
Gaj S, Thoomukuntla B, Ontaneda D, Nakamura K
J Neuroimaging. 2025; 35(1):e70024.
PMID: 39923192
PMC: 11807364.
DOI: 10.1111/jon.70024.
The role of circular RNAs in autoimmune diseases: Potential diagnostic biomarkers and therapeutic targets.
Li X, Wang J, Wang P, Qi S, Amalraj J, Zhou J
FASEB J. 2025; 39(2):e70263.
PMID: 39873909
PMC: 11774230.
DOI: 10.1096/fj.202401764R.
Inflammatory proteins related to depression in multiple sclerosis: A systematic review and meta-analysis.
Kiropoulos L, Rozenblat V, Baes N
Brain Behav Immun Health. 2025; 43:100939.
PMID: 39867847
PMC: 11758135.
DOI: 10.1016/j.bbih.2024.100939.
The current state of knowledge on the role of NKG2D ligands in multiple sclerosis and other autoimmune diseases.
Pogoda-Wesolowska A, Slugocka N, Synowiec A, Brodaczewska K, Mejer-Zahorowski M, Ziekiewicz M
Front Mol Neurosci. 2025; 17:1493308.
PMID: 39866909
PMC: 11758245.
DOI: 10.3389/fnmol.2024.1493308.
Vaccination coverage and its determinants in patients with multiple sclerosis-a multicenter cross-sectional study.
Schade P, Nguyen H, Steinle J, Hellwig K, Pelea T, Franken P
Ther Adv Neurol Disord. 2025; 18:17562864241309806.
PMID: 39866752
PMC: 11760134.
DOI: 10.1177/17562864241309806.
Effect of Different Treatments on Retinal Thickness Changes in Patients With Multiple Sclerosis: A Review.
Adibi A, Adibi I, Javidan M
CNS Neurosci Ther. 2025; 31(1):e70225.
PMID: 39853938
PMC: 11759887.
DOI: 10.1111/cns.70225.
RiboTag-based RNA-Seq uncovers oligodendroglial lineage-specific inflammation in autoimmune encephalomyelitis.
Wang Y, Ghimire S, Mangalam A, Kang Z
bioRxiv. 2025; .
PMID: 39764033
PMC: 11703255.
DOI: 10.1101/2024.12.24.630168.
Administration and Monitoring Burden of High-Efficacy Disease-Modifying Therapies for Multiple Sclerosis: A Delphi Consensus of Clinical Experts from Saudi Arabia.
Makkawi S, Abulaban A, Al Malik Y, Alshehri E, Althobaiti A, Aljarallah S
Neurol Ther. 2025; 14(1):413-427.
PMID: 39755895
PMC: 11762031.
DOI: 10.1007/s40120-024-00707-5.
Autoinjectors for Administering Glatiramer Acetate in Relapsing Remitting Multiple Sclerosis in Europe: A Survey of Patient and Nurse Preferences.
Shirol S, Saboor R, Muller T
Degener Neurol Neuromuscul Dis. 2024; 14:131-141.
PMID: 39723344
PMC: 11669291.
DOI: 10.2147/DNND.S484306.
Mapping cognitive dysfunction in relapsing multiple sclerosis with mild disability: A cross-sectional study from South India.
Nair S, Thulaseedharan J, Rajan N, Bava E, Nair G, Sundaram S
Mult Scler J Exp Transl Clin. 2024; 10(4):20552173241304302.
PMID: 39676817
PMC: 11639032.
DOI: 10.1177/20552173241304302.
Combining gene expression microarrays and Mendelian randomization: exploring key immune-related genes in multiple sclerosis.
Ding S, Zhang Y, Tang Y, Zhang Y, Liu M
Front Neurol. 2024; 15:1437778.
PMID: 39664749
PMC: 11631747.
DOI: 10.3389/fneur.2024.1437778.
Essential and toxic metal concentrations in biological samples of multiple sclerosis patients: A systematic review and meta-analysis.
Kooshki A, Farmani R, Amirabadizadeh A, Mehrpour O, Sanjari M, Nakhaee S
PLoS One. 2024; 19(12):e0313851.
PMID: 39642137
PMC: 11623488.
DOI: 10.1371/journal.pone.0313851.
Effect of Fingolimod on Lymphocyte Subsets in Patients With Relapsing Multiple Sclerosis.
Sarikaya C, Gacar G, Efendi H
Cureus. 2024; 16(10):e70715.
PMID: 39493195
PMC: 11530245.
DOI: 10.7759/cureus.70715.
Oral State and Salivary Cortisol in Multiple Sclerosis Patients.
Kapel-Regula A, Chojdak-Lukasiewicz J, Rybinska A, Dus-Ilnicka I, Radwan-Oczko M
Biomedicines. 2024; 12(10).
PMID: 39457590
PMC: 11504177.
DOI: 10.3390/biomedicines12102277.
